{"id":"W2625662684","doi":"10.1503/cmaj.170074","title":"Assessing the safety and immunogenicity of recombinant vesicular stomatitis virus Ebola vaccine in healthy adults: a randomized clinical trial","year":2017,"lang":"en","type":"article","venue":"Canadian Medical Association Journal","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"ca_institutions":"Nova Scotia Health Authority; Canadian Science Centre for Human and Animal Health; Izaak Walton Killam Health Centre","funders":"Medical Research and Materiel Command; Canadian Institutes of Health Research; Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense; Oak Ridge Institute for Science and Education; Canadian Immunization Research Network; Dalhousie University; Battelle; Public Health Agency; Public Health Agency of Canada; U.S. Department of Energy; U.S. Department of Defense","keywords":"Immunogenicity; Ebola virus; Medicine; Ebola vaccine; Vesicular stomatitis virus; Randomized controlled trial; Virology; Clinical trial; Vesicular Stomatitis; Ebolavirus; Recombinant DNA; Immunology; Virus; Internal medicine; Biology; Antibody","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0175234,0.0001016698,0.0007725968,0.0001619153,0.000727514,0.0001838186,0.0001861941,0.00033008,0.0004380468],"category_scores_gemma":[0.0217455,0.00006516343,0.0002474523,0.0001140345,0.0001534035,0.0001996743,0.00003969294,0.001458639,0.000006338324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005475237,"about_ca_system_score_gemma":0.002937286,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.03274773,"about_ca_topic_score_gemma":0.04939749,"domain_scores_codex":[0.9959736,0.001431222,0.001261361,0.000152049,0.0008165911,0.0003651201],"domain_scores_gemma":[0.9967456,0.001113591,0.0007400691,0.0002126414,0.0003696981,0.0008183882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3584464,0.0005297765,0.1419363,0.00008109209,0.0008484941,0.0007614268,0.0005432844,0.000001298101,0.00002826191,0.0002680624,0.004843997,0.4917115],"study_design_scores_gemma":[0.6341785,0.0007616437,0.3498749,0.0004577795,0.00009051494,0.0003357171,0.0002602072,0.002462893,0.000008048296,0.0001369353,0.01133175,0.0001010615],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9563103,0.0005017022,0.0001097182,0.0407251,0.001148411,0.0006201947,0.000006426394,0.000004647292,0.0005734683],"genre_scores_gemma":[0.9939817,0.003714163,0.00005835187,0.001403298,0.0007445446,0.00001132127,0.000004427939,0.00001013699,0.00007206237],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4916105,"threshold_uncertainty_score":0.9864948,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02770332975105257,"score_gpt":0.3924936291337212,"score_spread":0.3647902993826686,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}